Market Movers (8-K)
See all →OTC.Pink
Mountain Crest Acquisition Corp. V secured an unsecured promissory note for up to $500,000 from its sponsor, Mountain Crest Global Holdings LLC, for working capital.
Capital raise
OTC.Pink
Mountain Crest Acquisition Corp. V stockholders approved an extension to complete a business combination until November 16, 2026, elected a director, and ratified auditors.
Delay expected
OTC.Pink
Mountain Crest Acquisition Corp. V has appointed WWC, P.C. as its new independent auditor, replacing UHY LLP, with no reported disagreements but a prior 'going concern' warning.
Worse than expected
OTC.Pink
Mountain Crest Acquisition Corp. V obtained a $500,000 unsecured promissory note from its sponsor, Mountain Crest Global Holdings LLC, for working capital purposes.
Capital raise
OTC.Pink
Mountain Crest Acquisition Corp. V will be delisted from the Nasdaq Stock Market after failing to complete a business combination within the required 36-month timeframe.
Worse than expected
Delay expected
OTC.Pink
Mountain Crest Acquisition Corp. V has extended its deadline to complete a business combination to November 16, 2025, following shareholder approval at its annual meeting.
Quarterly Earnings (10-Q)
See all →OTC.Pink
10-Q: Mountain Crest Acquisition Corp. V Q2 2026 Update: Delisting and Business Combination Uncertainty
Mountain Crest Acquisition Corp. V's Q2 2026 Form 10-Q reveals significant challenges, including Nasdaq delisting and continued uncertainty regarding its business combination, alongside a net loss for the period.
Worse than expected
Capital raise
Delay expected
OTC.Pink
Mountain Crest Acquisition Corp. V reports Q1 2026 financials, detailing operational costs and progress towards a business combination.
Worse than expected
Capital raise
Delay expected
OTC.Pink
Mountain Crest Acquisition Corp. V reported a net loss for Q3 2025, extended its business combination deadline to November 2026, and continues to address going concern issues and internal control weaknesses.
Worse than expected
Delay expected
Capital raise
OTC.Pink
Mountain Crest Acquisition Corp. V, a delisted SPAC, reported increased net losses and significant related-party debt while pursuing a business combination with CUBEBIO by November 2025, raising substantial doubt about its going concern.
Worse than expected
Delay expected
Capital raise
OTC.Pink
Mountain Crest Acquisition Corp. V reports a net loss for Q1 2025 and navigates delisting challenges while pursuing a business combination with CUBEBIO Co., Ltd.
Delay expected
Worse than expected
Capital raise
OTC.Pink
Mountain Crest Acquisition Corp. V reported a net loss for the third quarter of 2024 and provided an update on its business combination agreement with CUBEBIO Co., Ltd.
Worse than expected
Delay expected
Capital raise
Annual Reports (10-K)
OTC.Pink
Mountain Crest Acquisition Corp. V reports its 10-K filing, highlighting a failed business combination deadline, subsequent delisting from Nasdaq, and ongoing efforts to secure a new merger target.
Delay expected
Capital raise
Worse than expected
OTC.Pink
Mountain Crest Acquisition Corp. V's annual report on Form 10-K details the company's registered securities, including units, common stock, and rights, as of December 31, 2023.
Capital raise
Insider Trading (Form 4)
See all →OTC.Pink
Mountain Crest Acquisition Corp. V's CEO and 10% owner, Suying Liu, reported the disposition of 200,000 common shares at $5 per share, contingent on the company's initial business combination.
OTC.Pink
Mountain Crest Global Holdings LLC reported the sale of 200,000 shares of Mountain Crest Acquisition Corp. V common stock at $5 per share, with transfer contingent on a business combination.
OTC.Pink
Suying Liu, CEO and CFO of Mountain Crest Acquisition Corp. V, sold 100,000 shares of common stock on February 17, 2025, at $7 per share.
OTC.Pink
Mountain Crest Global Holdings LLC, a 10% owner of Mountain Crest Acquisition Corp. V, sold 100,000 shares of common stock on February 17, 2025.
OTC.Pink
CUBEBIO, a Korean in-vitro diagnostic company, plans to go public on Nasdaq through a business combination with Mountain Crest Acquisition Corp. V, valuing CUBEBIO at $375 million.
OTC.Pink
Form 4: Mountain Crest Acquisition Corp. V: CEO and CFO, Suying Liu, Reports Changes in Beneficial Ownership
Suying Liu, CEO and CFO of Mountain Crest Acquisition Corp. V, reports acquiring beneficial ownership of 2,165,800 shares of common stock and rights to purchase common stock through Mountain Crest Global Holdings LLC.
Proxy Statements (Def-14A)
OTC.Pink
Mountain Crest Acquisition Corp. V is seeking stockholder approval to extend its business combination deadline to November 16, 2026, to finalize its merger with CUBEBIO Co., Ltd.
Delay expected
Capital raise
OTC.Pink
DEF 14A: Mountain Crest Acquisition Corp. V Seeks Extension to Complete Business Combination with CUBEBIO
Mountain Crest Acquisition Corp. V is seeking stockholder approval to extend the deadline for completing a business combination to November 16, 2025, to finalize its merger with CUBEBIO Co., Ltd.
Delay expected
Worse than expected
Schedule 13G - Passive Investments
OTC.Pink
Mountain Crest Global Holdings LLC and its sole manager, Suying Liu, have reported beneficial ownership of 64.94% of Mountain Crest Acquisition Corp. V's common stock.
OTC.Pink
SCHEDULE 13G/A: Mountain Crest Acquisition Corp. V Reports Major Shareholder's Continued Dominant Stake
Mountain Crest Global Holdings LLC and its sole manager, Suying Liu, have filed an updated Schedule 13G, reaffirming their beneficial ownership of 74.63% of Mountain Crest Acquisition Corp. V's common stock.